1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Epigenetics Revenue
1.4 Market by Type
1.4.1 Global Epigenetics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 DNA Methylation
1.4.3 Histone Modifications
1.4.4 Other Technologies
1.5 Market by Application
1.5.1 Global Epigenetics Market Share by Application: 2020 VS 2026
1.5.2 Oncology
1.5.3 Metabolic Diseases
1.5.4 Developmental Biology
1.5.5 Immunology
1.5.6 Cardiovascular Diseases
1.5.7 Other Applications
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Epigenetics Market Perspective (2015-2026)
2.2 Global Epigenetics Growth Trends by Regions
2.2.1 Epigenetics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Epigenetics Historic Market Share by Regions (2015-2020)
2.2.3 Epigenetics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Epigenetics Market Growth Strategy
2.3.6 Primary Interviews with Key Epigenetics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Epigenetics Players by Market Size
3.1.1 Global Top Epigenetics Players by Revenue (2015-2020)
3.1.2 Global Epigenetics Revenue Market Share by Players (2015-2020)
3.1.3 Global Epigenetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Epigenetics Market Concentration Ratio
3.2.1 Global Epigenetics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Epigenetics Revenue in 2019
3.3 Epigenetics Key Players Head office and Area Served
3.4 Key Players Epigenetics Product Solution and Service
3.5 Date of Enter into Epigenetics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Epigenetics Historic Market Size by Type (2015-2020)
4.2 Global Epigenetics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Epigenetics Market Size by Application (2015-2020)
5.2 Global Epigenetics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Epigenetics Market Size (2015-2020)
6.2 Epigenetics Key Players in North America (2019-2020)
6.3 North America Epigenetics Market Size by Type (2015-2020)
6.4 North America Epigenetics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Epigenetics Market Size (2015-2020)
7.2 Epigenetics Key Players in Europe (2019-2020)
7.3 Europe Epigenetics Market Size by Type (2015-2020)
7.4 Europe Epigenetics Market Size by Application (2015-2020)
8 China
8.1 China Epigenetics Market Size (2015-2020)
8.2 Epigenetics Key Players in China (2019-2020)
8.3 China Epigenetics Market Size by Type (2015-2020)
8.4 China Epigenetics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Epigenetics Market Size (2015-2020)
9.2 Epigenetics Key Players in Japan (2019-2020)
9.3 Japan Epigenetics Market Size by Type (2015-2020)
9.4 Japan Epigenetics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Epigenetics Market Size (2015-2020)
10.2 Epigenetics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Epigenetics Market Size by Type (2015-2020)
10.4 Southeast Asia Epigenetics Market Size by Application (2015-2020)
11 India
11.1 India Epigenetics Market Size (2015-2020)
11.2 Epigenetics Key Players in India (2019-2020)
11.3 India Epigenetics Market Size by Type (2015-2020)
11.4 India Epigenetics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Epigenetics Market Size (2015-2020)
12.2 Epigenetics Key Players in Central & South America (2019-2020)
12.3 Central & South America Epigenetics Market Size by Type (2015-2020)
12.4 Central & South America Epigenetics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 IlluminA
13.1.1 IlluminA Company Details
13.1.2 IlluminA Business Overview
13.1.3 IlluminA Epigenetics Introduction
13.1.4 IlluminA Revenue in Epigenetics Business (2015-2020))
13.1.5 IlluminA Recent Development
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Details
13.2.2 Thermo Fisher Scientific Business Overview
13.2.3 Thermo Fisher Scientific Epigenetics Introduction
13.2.4 Thermo Fisher Scientific Revenue in Epigenetics Business (2015-2020)
13.2.5 Thermo Fisher Scientific Recent Development
13.3 Merck Millipore
13.3.1 Merck Millipore Company Details
13.3.2 Merck Millipore Business Overview
13.3.3 Merck Millipore Epigenetics Introduction
13.3.4 Merck Millipore Revenue in Epigenetics Business (2015-2020)
13.3.5 Merck Millipore Recent Development
13.4 Abcam
13.4.1 Abcam Company Details
13.4.2 Abcam Business Overview
13.4.3 Abcam Epigenetics Introduction
13.4.4 Abcam Revenue in Epigenetics Business (2015-2020)
13.4.5 Abcam Recent Development
13.5 Active Motif
13.5.1 Active Motif Company Details
13.5.2 Active Motif Business Overview
13.5.3 Active Motif Epigenetics Introduction
13.5.4 Active Motif Revenue in Epigenetics Business (2015-2020)
13.5.5 Active Motif Recent Development
13.6 Bio-Rad
13.6.1 Bio-Rad Company Details
13.6.2 Bio-Rad Business Overview
13.6.3 Bio-Rad Epigenetics Introduction
13.6.4 Bio-Rad Revenue in Epigenetics Business (2015-2020)
13.6.5 Bio-Rad Recent Development
13.7 New England Biolabs
13.7.1 New England Biolabs Company Details
13.7.2 New England Biolabs Business Overview
13.7.3 New England Biolabs Epigenetics Introduction
13.7.4 New England Biolabs Revenue in Epigenetics Business (2015-2020)
13.7.5 New England Biolabs Recent Development
13.8 Agilent
13.8.1 Agilent Company Details
13.8.2 Agilent Business Overview
13.8.3 Agilent Epigenetics Introduction
13.8.4 Agilent Revenue in Epigenetics Business (2015-2020)
13.8.5 Agilent Recent Development
13.9 Qiagen
13.9.1 Qiagen Company Details
13.9.2 Qiagen Business Overview
13.9.3 Qiagen Epigenetics Introduction
13.9.4 Qiagen Revenue in Epigenetics Business (2015-2020)
13.9.5 Qiagen Recent Development
13.10 Zymo ResearcH
13.10.1 Zymo ResearcH Company Details
13.10.2 Zymo ResearcH Business Overview
13.10.3 Zymo ResearcH Epigenetics Introduction
13.10.4 Zymo ResearcH Revenue in Epigenetics Business (2015-2020)
13.10.5 Zymo ResearcH Recent Development
13.11 Perkinelmer
10.11.1 Perkinelmer Company Details
10.11.2 Perkinelmer Business Overview
10.11.3 Perkinelmer Epigenetics Introduction
10.11.4 Perkinelmer Revenue in Epigenetics Business (2015-2020)
10.11.5 Perkinelmer Recent Development
13.12 Diagenode
10.12.1 Diagenode Company Details
10.12.2 Diagenode Business Overview
10.12.3 Diagenode Epigenetics Introduction
10.12.4 Diagenode Revenue in Epigenetics Business (2015-2020)
10.12.5 Diagenode Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
【掲載企業】
IlluminA、Thermo Fisher Scientific、Merck Millipore、Abcam、Active Motif、Bio-Rad、New England Biolabs、Agilent、Qiagen、Zymo ResearcH、Perkinelmer、Diagenode
【免責事項】
https://www.globalresearch.jp/disclaimer